Detalhe da pesquisa
2.
Whole-transcriptome sequencing in advanced gastric or gastroesophageal cancer: A deep dive into its clinical potential.
Cancer Sci
; 115(5): 1622-1633, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38429886
3.
Three-year outcomes of preoperative chemoradiotherapy plus nivolumab in microsatellite stable and microsatellite instability-high locally advanced rectal cancer.
Br J Cancer
; 2024 Jun 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38834744
4.
Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study.
Lancet
; 402(10395): 41-53, 2023 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37331369
5.
Prognostication in Lymph Node-Positive Prostate Cancer with No PSA Persistence After Radical Prostatectomy.
Ann Surg Oncol
; 31(6): 3872-3879, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38353798
6.
SEAMARK: phase II study of first-line encorafenib and cetuximab plus pembrolizumab for MSI-H/dMMR BRAFV600E-mutant mCRC.
Future Oncol
; 20(11): 653-663, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-37815847
7.
Cetuximab every 2 weeks versus standard weekly dosing administration schedule.
Future Oncol
; 20(7): 393-407, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37850363
8.
Phase II trial of niraparib for BRCA-mutated biliary tract, pancreatic and other gastrointestinal cancers: NIR-B.
Future Oncol
; : 1-7, 2024 Apr 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38629456
9.
Bridging horizons beyond CIRCULATE-Japan: a new paradigm in molecular residual disease detection via whole genome sequencing-based circulating tumor DNA assay.
Int J Clin Oncol
; 29(5): 495-511, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38551727
10.
Learning Outcomes of "GetSMART," Education for Diagnostics and Targeted Treatment for HER2+ Metastatic Gastric and Colorectal Cancers.
J Cancer Educ
; 39(2): 118-125, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38135836
11.
[Chemotherapy for Unresectable Advanced, Metastatic or Recurrent Colorectal Cancer].
Gan To Kagaku Ryoho
; 51(3): 245-249, 2024 Mar.
Artigo
em Japonês
| MEDLINE | ID: mdl-38494801
12.
Pembrolizumab in Asian patients with microsatellite-instability-high/mismatch-repair-deficient colorectal cancer.
Cancer Sci
; 114(3): 1026-1036, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36369901
13.
Trifluridine/tipiracil+bevacizumab (BEV) vs. fluoropyrimidine-irinotecan+BEV as second-line therapy for metastatic colorectal cancer: a randomised noninferiority trial.
Br J Cancer
; 128(10): 1897-1905, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36871043
14.
Clinical significance of circulating-tumour DNA analysis by metastatic sites in pancreatic cancer.
Br J Cancer
; 128(8): 1603-1608, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36782009
15.
Mutational spectrum of TP53 gene correlates with nivolumab treatment efficacy in advanced gastric cancer (TP53MUT study).
Br J Cancer
; 129(6): 1032-1039, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37532830
16.
Prevalence of KRAS G12C Mutation and Co-mutations and Associated Clinical Outcomes in Patients With Colorectal Cancer: A Systematic Literature Review.
Oncologist
; 28(11): e981-e994, 2023 Nov 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37432264
17.
Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer.
N Engl J Med
; 383(23): 2207-2218, 2020 12 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33264544
18.
NEXUS trial: a multicenter phase II clinical study evaluating the efficacy and safety of the perioperative use of encorafenib, binimetinib, and cetuximab in patients with previously untreated surgically resectable BRAF V600E mutant colorectal oligometastases.
BMC Cancer
; 23(1): 779, 2023 Aug 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37605122
19.
Aflibercept with FOLFIRI in Japanese patients with metastatic colorectal cancer: results of a post-marketing surveillance.
Int J Clin Oncol
; 28(1): 130-138, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36307632
20.
Encorafenib, binimetinib, and cetuximab in BRAF V600E-mutated colorectal cancer: an early post-marketing phase vigilance study.
Int J Clin Oncol
; 28(1): 139-144, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36355316